NOVARTIS for NOVARTIS
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Free Trade Agreements: - Intellectual Property Provisions in Peru, Columbia, Korea
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HALLER | — |
Copyright/Patent/Trademark CPT
S 1145 - Patent Reform Act of 2007 HR 1908 - Patent Reform Act of 2007
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARGUERITE BAXTER | — |
| DANIEL CASSERLY | — |
| DAVID DRAKE | — |
| JAMES ELKIN | — |
| THOMAS GILES | — |
| SARAH HALLER | — |
| GENE HUGHES | — |
| BRENDA J LUCKRITZ | — |
| KATHERINE SOLON | — |
Health Issues HCR
HR 4703, S 2467, HR 4991 - Vaccine Shortage preparedness Act of 2008 S 2464, HR 4992, HR 4704 - A bill to amend title XVIII of the Social Security Act to provide for coverage of federally recommended vaccines under Medicare Part B S 2465 - Vaccines for Children Access Act of 2008 HR 5839 - Safeguarding America's Pharmaceuticals Act of 2008 S 3408 - Comparative Effectiveness Research Act of 2008 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 S 2467 - Vaccine shortage preparedness Act of 2008 S 3678 - /PL 109-417 All pandemic and all-hazards act - Section 317 program issues HR 970 and S 1378 - Dextromethorphan Distribution Act of 2007 S 103 - Combat Meth Act of 2005 HR 2207 - Agricultural Disaster Assistance and Western States Emergency - Unfinished business Appropriations Act of 2007 HR 1908 and S 1710 Patent Reform Act of 2007 HR 1 - Implementing the 9/11 Commission recommendations Act of 2007 HR 3162 - Children's Health and Medicare Protection Act of 2007 S 1505 - Affordable Biologics for Consumers Act S 1695 - Biologics Price Competition and Innovation Act of 2007 HR 1956 - Patent Protection and Innovative Biologic Medicines Act of 2007 HR 1038, S623 - Access to Life-Saving Medicine Act HR 4083 - Non-prescription Drug Modernization Act of 2007 HR 1308 - Legal Immigrant Children's Health Improvement Act of 2007 HR 5629 - Pathway for Biosimilars Act Comparative Effectiveness Research Public Health Service Act Drug Importation Gene Therapy Direct to Consumer Advertising Drug Safety Legislation Global Hypertension
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARGUERITE BAXTER | — |
| DANIEL CASSERLY | — |
| DAVID DRAKE | — |
| JAMES ELKIN | — |
| THOMAS GILES | — |
| SARAH HALLER | — |
| GENE HUGHES | — |
| BRENDA J LUCKRITZ New | — |
| KATHERINE SOLON | — |
Medicare/Medicaid MMM
S 2029 - Physician Payments Sunshine Act of 2007 HR 6111 - Tax Relief and Healthcare Act (Medicare) Access to Life Saving Medicines Act Medicare Part B and Part D - Part D: Non-Interference/Part B: Prompt Pay Removal from Average Sales Price Calculation HR 6331 - Medicare Improvements for Patients and Providers Act of 2008 HR 2184 - Enhanced Health Care Value for all Act of 2007 HR 3023 Drug and Medical Device Company Gift Disclosure Act HR 3963 Children's Health Insurance Program Reauthorization Act of 2007 S 2041, HR 4854 - False Claims Act of Correction Act of 2007 HR 3610 - Food and Drug Import Safety Act of 2007 Medicare Prescription Drugs and Modernization Act Immunosuppressant Legislation
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARGUERITE BAXTER | — |
| DANIEL CASSERLY | — |
| DAVID DRAKE | — |
| JAMES ELKIN | — |
| THOMAS GILES | — |
| SARAH HALLER | — |
| GENE HUGHES | — |
| BRENDA J LUCKRITZ | — |
| KATHERINE SOLON | — |
Budget/Appropriations BUD
DoD Authorization Language - Section 701 - Dealing with TriCare HR 3282 - Comprehensive Immunosuppressive drug Coverage for Kidney Transplant Patients Act of 2007 FY 2009 - Labor HHS Appropriations Bill - Pandemic Influenza Funding and Weldon Ammendment on Thimerosal and Vaccines LHHS Appropriations, Pandemic Influenza Funding HR 2642, S 3230 - 2008 Supplemental Appropriations Bill FY 2009 Department of Defense Appropriations Bill - Transformational Medical Initiative HR 2638 - Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 2009 S 3604 - A bill making supplemental appropriations for economic recovery for fiscal year ending 9/30/08 (economic stimulus package) HR 7110 - Job Creation and Unemployment Relief Act of 2008
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARGUERITE BAXTER | — |
| DANIEL CASSERLY | — |
| DAVID DRAKE | — |
| JAMES ELKIN | — |
| THOMAS GILES | — |
| SARAH HALLER | — |
| GENE HUGHES | — |
| BRENDA J LUCKRITZ New | — |
| KATHERINE SOLON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.